Immunization Flashcards
National immunization Program
BCG
Monovalent Hep B
DPT-HiB-Hep B
OPV
Bacillus Calmette Guerin (BCG)
Intradermally
Live attenuated
Given at the earliest possible age after birth
(first 2 months)
<12 months: 0.05 ml
>12 months: 0.1 ml
Hepatitis B vaccine
Intramuscular
1st dose: birth or within 12 hours of life
minimum interval: 4 weeks
Final dose: not earlier than age 24 weeks
Another dose is needed if last dose >24 weeks
Hepatitis B
Preterm
(mother: HBsAg (-) )
1st dose may be given at 30 days of age regardless of weight
Another dose of HBV is need for those <2 kgs whose 1st dose was received at birth
Hep B vaccine
Preterm
(mother HBsAg (+)
administer HBV and HBIG (0.5ml) within 12 hours of life
HBIG should be administered not later than 7 days of age
DPT
IM
minimum age: 6 weeks
minimum interval: 4 week
(6-10-14-16-20)
recommended interval between 3rd and 4th dose : 6 months, 4 months is valid)
5th dose may not be given if the 4th dose was administered at age 4 years or older
HiB
IM
3 dose primary series
Minimum age: 6 weeks
minimum interval: 4 weeks
booster: given between 12-15 months with an interval of 6 months from the 3rd dose
Poliovirus vaccine
OPV: per orem
IPV: IM
3 dose primary series
Minimum age: 6 weeks
Minimum interval: 4 week
A booster dose should be given on or after the 4th birthday and at least 6 months from the previous dose
PCV
IM
minimum age: 6 weeks
3 doses with an interval of at least 4 weeks
booster given at 6 months after the 3rd dose
Healthy children 2 to 5 years who have no previous PCV vaccination may be given 1 dose of PCV13 or 2 doses of PCV 10 at least 8 weeks apart
Routine use of PCV is npt recommended for healthy children 5 years and above
Rotavirus
PO
minimum age: 6 weeks
interval: 4 weeks
Last dose should be given not later than 32 weeks of age
Monovalent human rotavirus vaccine 1 (RV1)
2 dose series
Pentavalent bovine rotavirus vaccine (RV5)
3 dose series
Influenza vaccine
Trivalent: IM or SC
Quadrivalent; IM
minimum age: 6 months
6 months - 35 months : 0.25 ml
36 months to 18 years: 0.5 ml
Children 6months to 8 years receiving influenza vaccine for the first time should receive 2 doses separated by at least 4 weeks. If only 1 dose was given , give 2 dose of the vaccine then 1 dose of vaccine thereafter
Children aged 9 - 18 years should receive 1 dose of vaccine yearly
Measles vacine
Live attenuated
SC
age: 9 months but may be given as early as 6 month in cases of outbreaks
Japanese Encephalitis
SC
age: 9 months
Children 9 months to 17 years of age should receive 1 primary dose followed by a booster 12-24 months after the primary dose
Individual 18 years and older should receive a single dose only
MMR
SC
Live attenduated
minimum age: 12 months. may be given at early age if recommended by public health authorities
Minimum interval: 4 weeks
2 doses of MMR are recommended.
2nd dose: 4-6 years
Children below 12 months given any measles containing vaccine should be given 2 additional doses
Varicella
SC
live attenuated
minimum age: 12 months
2 doses
1st dose: 12-15 months
2nd dose: 4-6 years
<13 years old: interval : 3 months. However id f the 2nd dose was administered at least 4 weeks after the first dose, it s considered valid
> 13 years old: 4 weeks interval
MMRV
SC
Live attenuatad
minimum age: 12 months
Max age: 12 years
Minimum interval: 3 months
Hepatitis A
IM
age: 12 months
2 dose
interval: 6 months
Tdap
IM
* for children who are fully immunized, Td should be given every 10 years’
- for fully immunized pregnant adolescent, 1 dose of tdap anytime after 20 weeks
- Unimmunized pregnant adolescent, 3 dose Tdap (0,1,6 month) Tdap should replace one dose of Td given preferrably after 20 weeks of gestation
HPV
IM
3 dose series
age: 9 years
Bivalent: 0,1,6 months
Quadrivalent: 0,2,6 months
Interval: 1 month then 3 months
Quadrivalent: can be given to males 9 to 18 years of age for the prevention of anogenital warts
Rabies
IM or ID
IM: purified Vero cell Rabies Vaccine 9PVRV) 0.5 ml or Purified Chick Embryo cell Vaccine (PCEVC) 1 ml
0,7,21 or 28
ID: 0.1 ml on 0, 7, 21 or 28
Typhoid vaccine
IM
age: 2 years olf with revaccination every 2-3 years
Dengue vaccine
Live attenuated SQ age: 9 years Max age: 45 years old 3 doses (0, 6,12)
Cholera
PO
minimum age: 12 months
2 dose series (2 weeks apart)
Meningococcal vaccine
Tetravalent menigococcal (ACYW-135) conjugate vaccine (MCV4-d, MCV4 TT, MCV4-CRM) given intramuscularly (IM)
Tetravalent menigococcal polysaccharide vaccine (MPS4) given IM or SC
Indicated for those at high risk for invasive disease: persistent complement component deficiencies, anatomic/functional asplenia, HIV
MCV4-D
age: 9 months
9-23 months, 2 doses at 3months apart
2 years and above: 1 dose
Revaccinate: after 5 years
MCV4-TT
children 12 months and above as single dose
Revaccinate: after 5 years
MCV4-CRM
2 years and above as single dose
Revaccinate: after 5 years
MPSV4
2 years and above as single dose
Pneumococcal conjugate (PCV) Pneumococcal Polysaccharide (PPSV)
IM
for children with high risk medical conditions (chronic heart, lung, kidney, DM, CSF leak, cochlear iplant, sickle cell, hemoglobinopatjies, asplenia, HIV)
2- 5 yearsL
1 dose of PCV13 if an incomplete 3 dose of PCV
2 dose of PCV13 at least 8 weeks apart
Give supplemental dose of PCV13 if 4 doses of PCV7 or other series was given
For children with no histor of PPSV vaccination; give PPSV at least 8 weeks after the most recent PCV13
6-18 years:
1 dose of PCV13 followed by 1 dose of PPSV atleast 8 weeks
1 dose of PPSV at least 8 weeks after the most recnt PCV 13 if the precious PCV13 but s PPSV immunization
single dose of PPSV at least 8 weeks after the last dose of PCV13 in children with no history of PPSV immunization
HiB
IM
12-59 months:
- Unimmunized or wit 1 dose of Hib before age of 12 (GIVE ADDITIONAL 2 DOSES 8 WEEKS APART)
- Give >2 doses of Hib before age of 12 months, (GIVE 1 ADDITIONAL DOSE)
Viral Live Attenuated Vaccines
MMR Varicerlla Yellow Fever Rotavirus OPV Intranasal influenza
Bacterial LIve Attenuated
BCG
Viral Inactivated
Polio
Hep A
Rabies
Influenza
Bacterial Inactivated
Pertussis, Typhoid, Cholera
Sub-unit Inactivated
Hep B Influenza Acellular Pertussis HPV Lyme
Toxoid Inactivated
Diptheria
Tetanus
Pure Polyssacharide Vaccines
Pneumococcal
Meningococcal
S. Typhi (Vi)
Conjugate Polysaccharide Vaccines
Pneumococcal, Meningococcal, Hib
